SCHEMBL723372

SCHEMBL723372

CCN(CC)c1ccc(C=NNC(=O)c2ccncc2)c(O)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.72
MAPT P10636 12/20 0.72
NPC1 O15118 7/20 0.72
RAB9A P51151 7/20 0.72
HTT P42858 7/20 0.72
KMT2A Q03164 6/20 0.72
MEN1 O00255 5/20 0.72
CA12 O43570 1/20 0.72
CA1 P00915 1/20 0.72
CA2 P00918 1/20 0.72
CA9 Q16790 1/20 0.72
ALDH1A1 P00352 8/20 0.66
HPGD P15428 4/20 0.66
GAA P10253 3/20 0.66
HCRTR1 O43613 1/20 0.64
SMN1; SMN2 Q16637 5/20 0.64
LMNA P02545 4/20 0.64
CASP3 P42574 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
SENP8 Q96LD8 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29382751 1.00 KDM4E (0.72) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL5809052 1.00 KDM4E (0.72) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL5815393 1.00 KDM4E (0.72) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL12746378 0.87 CA12 (0.77) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL28520457 0.87 MAPT (0.73) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL14195185 0.87 MAPT (0.73) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL12746253 0.86 CA12 (0.75) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL10049642 0.86 CA12 (0.75) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL10049932 0.84 MAPT (0.74) KDM4EMAPTNPC1RAB9AHTT
SCHEMBL10049962 0.82 CA12 (0.66) KDM4EMAPTNPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139647-A Conjugates of glucagon and AMPK activators 哥本哈根大学 2024-06-04 CN claimed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO claimed
CN-118139647-A Conjugates of glucagon and AMPK activators 哥本哈根大学 2024-06-04 CN disclosed
WO-2012027548-A1 COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF ALZHEIMER'S AND OTHER DISEASES THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) 2012-03-01 WO disclosed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed